Genetics – Barrier Free Japan

by Michael Gillan Peckitt February 23, 2026 0

Regenerative Medicine Clinic in Tokyo Gets Business Improvement Order [Podcast Episode]

Japan’s health ministry ordered a clinic in Tokyo to improve its operations on Friday 20th February over its violations of the law on safety in regenerative medicine. An on-site inspection of Ginza Phoenix Clinic found violations, including administrations of cultured cells using stem cells and dendritic cells by five doctors not listed in 10 regenerative medicine plans submitted by its director, Hisashi Nagai, to the ministry. Medical institutions face penalties for false or missing entries in mandatory regenerative medicine treatment plans.

by Michael Gillan Peckitt February 21, 2026 0

Disability Genetics Japan Medical

Regenerative Medicine Clinic in Tokyo Gets Biz Improvement Order

Japan’s health ministry ordered a clinic in Tokyo to improve its operations Friday over its violations of the law on safety in regenerative medicine. An on-site inspection of Ginza Phoenix Clinic found violations, including administrations of cultured cells using stem cells and dendritic cells by five doctors not listed in 10 regenerative medicine plans submitted by its director, Hisashi Nagai, to the ministry. Medical institutions face penalties for false or missing entries in mandatory regenerative medicine treatment plans.

by Michael Gillan Peckitt February 14, 2026 1

Disability Genetics Health Japan Medical

Japan Approves Muscular Dystrophy Drug Price of 300 M. Yen

An advisory panel to Japan’s health minister decided Friday to allow public health insurance coverage for a gene therapy for muscular dystrophy beginning Feb. 20 and set the drug’s official price at about 304.97 million yen.   Elevidys, a one-time treatment for Duchenne muscular dystrophy in ambulatory patients aged 3-7, will become the country’s most expensive drug.

by Michael Gillan Peckitt December 8, 2025 0

Eugenics Fertility Genetics Japan Podcast

Japan Eyes Ban on Gene-Edited Babies [Podcast Episode]

Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over “designer babies.” A Japanese government expert panel broadly approved a proposal, including the ban, at a meeting on Thursday 4th December.

by Michael Gillan Peckitt December 5, 2025 1

Disability Eugenics Genetics Japan

Japan Eyes Ban on Gene-Edited Babies

Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over “designer babies.” A Japanese government expert panel broadly approved a proposal, including the ban, at a meeting Thursday.

by Michael Gillan Peckitt September 2, 2025 1

Disability Down Syndrome Genetics Japan

Mie University Researchers Develop Groundbreaking CRISPR Technique to Remove Extra Chromosome in Down Syndrome Cells

Led by Dr. Ryotaro Hashizume of the Graduate School of Medicine, Unit for Genomic Manipulation and Technology Development, the team had successfully developed a technique to eliminate the extra copy of chromosome 21 in cells derived from individuals with Down syndrome. The condition, caused by trisomy 21, affects roughly one in every 700 births and leads to intellectual disabilities and other health complications.

by Michael Gillan Peckitt June 15, 2023 0

Disability Genetics Japan Medical

Japan Team Identifies Mutations Linked to Brain Aneurysms

A Japanese research team has identified gene mutations involved in the development of brain aneurysms, a discovery that raises hopes for pharmaceutical treatment of the condition.

About 5 pct of Japanese people are said to have brain aneurysms that have not ruptured. But the only treatment available is surgical procedures such as those using vascular catheters and craniotomy, in which part of the skull is temporarily removed.

by Michael Gillan Peckitt June 15, 2023 0

Genetics iPS Japan Transplantation

Japan Group Starts iPS Cell Supplies with Less Rejection Risk

When a transplant is performed, rejection occurs if the type of human leukocyte antigens, or HLA, of the donor does not conform with that of the recipient.

Using genome-editing technology, the foundation altered genes related to immune cells to create the iPS cells with lower rejection risk.

by Michael Gillan Peckitt February 5, 2022 0

Children Genetics Japan

Japanese University Team Finds Causes of Unexplained Diseases in Babies

A Japanese team led by Keio University said Friday that it has succeeded in identifying in a study using genome analyses the causes of diseases in about half of babies that had been unknown.

by Michael Gillan Peckitt January 14, 2022 0

Disability Genetics iPS Japan

World’s 1st iPS Therapy for Spinal Cord Injuries Starts in Japan

Japan’s Keio University said Friday it has started a clinical research to transplant neural progenitor cells derived from induced pluripotent stem, or iPS, cells into patients with spinal cord injuries, the first such attempt in the world.